Generex Biotechnology Corporation
OTC: GNBT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph Moscato
- Employees
- 15
- Headquarters
- Miramar, United States
- IPO year
- 1998
- Website
- https://generex.com/index.html
Loading GNBT…
Loading profile data…Frequently asked questions about GNBT
What does Generex Biotechnology Corporation (GNBT) do?
Founded in 1983 and headquartered in Miramar, Florida, Generex Biotechnology Corporation initially specialized in the delivery of large molecule drugs into the oral cavity via a portable aerosol applicator for use in Canada and the United States, notably offering Generex Oral-lyn, an oral insulin product. The company also had a significant focus...
Where does GNBT trade?
Generex Biotechnology Corporation (GNBT) trades on the Other OTC.
What sector is GNBT in?
Generex Biotechnology Corporation (GNBT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Generex Biotechnology Corporation?
Joseph Moscato is the chief executive officer of Generex Biotechnology Corporation (GNBT).
Where is Generex Biotechnology Corporation headquartered?
Generex Biotechnology Corporation is headquartered in United States.
Does GNBT pay a dividend?
Generex Biotechnology Corporation (GNBT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNBT go public?
Generex Biotechnology Corporation (GNBT) completed its initial public offering in 1998.